SCHEMBL21378029

SCHEMBL21378029

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1c(C#N)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-c2ccc(-n3c4cnccc4c4ccncc43)cc2)c1-n1c2ccc(C)cc2c2cc(C)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 4/20 0.39
GAA P10253 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
RXFP1 Q9HBX9 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
USP14 P54578 1/20 0.34
ELANE P08246 2/20 0.34
PDE9A O76083 2/20 0.33
LMNA P02545 2/20 0.32
DHODH Q02127 1/20 0.32
PDE10A Q9Y233 1/20 0.32
AR P10275 2/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396606 0.96 PDE9A (0.37) KDM4EALDH1A1HPGDGAAMEN1
SCHEMBL21396902 0.96 PDE9A (0.37) KDM4EALDH1A1HPGDGAAMEN1
SCHEMBL21378023 0.90 PDE9A (0.37) KDM4EALDH1A1HPGDGAAMEN1
SCHEMBL21378005 0.90 PDE9A (0.37) KDM4EALDH1A1HPGDGAAMEN1
SCHEMBL21378085 0.90 ELANE (0.37) KDM4EALDH1A1HPGDRXFP1CYP1A2
SCHEMBL21377974 0.88 PDE9A (0.32) KDM4EALDH1A1HPGDGAAMEN1
SCHEMBL21378007 0.87 CYP11B2 (0.38) KDM4EALDH1A1HPGDGAARXFP1
SCHEMBL21378011 0.85 CYP11B2 (0.40) KDM4EALDH1A1HPGDGAAMEN1
SCHEMBL21396871 0.85 CYP11B2 (0.37) KDM4EALDH1A1MEN1KMT2ARXFP1
SCHEMBL21396865 0.85 CYP11B2 (0.37) KDM4EALDH1A1MEN1KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11608333-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-03-21 US disclosed
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 KDM4E 4364/4885ALDH1A1 242/4885HPGD 2163/4885
US-11608333-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 KDM4E 4364/4885ALDH1A1 242/4885HPGD 2163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.